von Graffenried, Thea; Safroneeva, Ekaterina; Braegger, Christian; Ezri, Jessica; Garzoni, Luca; Giroud Rivier, Alexa; Greuter, Thomas; Köhler, Henrik; McLin, Valerie A; Marx, George; Müller, Pascal; Petit, Laetitia Marie; Schibli, Susanne; Sokollik, Christiane; Tempia-Caliera, Michela; Zwahlen, Marcel; Schoepfer, Alain M; Nydegger, Andreas (2024). Pediatric Patients with Eosinophilic Esophagitis and Their Parents Identify Symptoms as the Most Important Treatment Outcome. International archives of allergy and immunology, 185(6), pp. 527-535. Karger 10.1159/000535242
![[img]](https://boris.unibe.ch/style/images/fileicons/text.png) |
Text
vonGraffenried_IntArchAllergyImmunol_2024.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (385kB) |
INTRODUCTION
Given the lack of data, we aimed to explore which therapeutic endpoints pediatric patients with eosinophilic esophagitis (EoE) and their parents consider to be relevant.
METHODS
We created an educational brochure on EoE and a questionnaire, both of which were content-validated by pediatric patients and parents. Validated documents were sent to 112 patients and parents. They ranked the importance (5 levels) of short (during next 3 months) and long-term (≥1 year) treatment effect on symptoms, quality of life, endoscopic inflammation, stricture formation, histological inflammation, and fibrosis.
RESULTS
A total of 45 parents and 30 pediatric patients ≥11 years completed the questionnaires. Pediatric patients identified improvement in the following domains as most important in the short- and long-term, respectively: symptoms (73% vs. 77%), QoL (53% vs. 57%), histologic inflammation (47% vs. 50%), histologic fibrosis (40% vs. 33%), endoscopic inflammation (47% vs. 40%), and strictures (33% vs. 40%). Parents of children ≥11 years old classified improvement in the following domains as most important in the short- and long-term, respectively: symptoms (70% vs. 83%), QoL (63% vs. 80%), histologic inflammation (67% vs. 77%), histologic fibrosis (47% vs. 63%), endoscopic inflammation (77% vs. 80%), and strictures (40% vs. 53%). Agreement between caregiver and children on the short-term importance of treatment outcomes was as follows: symptoms (77%), QoL (40%), histologic inflammation and fibrosis (47% and 43%), endoscopic inflammation and strictures (50% and 40%).
CONCLUSION
Pediatric patients and parents attributed most importance to improvement in symptoms and QoL. Agreement between parents and patients regarding therapy goals is limited.
Actions (login required)
 |
Edit item |